Three cases of treatment with nafamostat in elderly patients with COVID-19 pneumonia who need oxygen therapy

No effective treatment for COVID-19 has been well established yet. Nafamostat, known as anticoagulant, has potential anti-inflammatory and anti-viral activities against COVID-19. We report three cases of COVID-19 pneumonia who progressed while using antiviral drugs and needed supplementary oxygen th...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Sukbin, Rhee, Ji-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250091/
https://www.ncbi.nlm.nih.gov/pubmed/32470602
http://dx.doi.org/10.1016/j.ijid.2020.05.072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250091/
https://www.ncbi.nlm.nih.gov/pubmed/32470602
http://dx.doi.org/10.1016/j.ijid.2020.05.072

Ejemplares similares